Entering text into the input field will update the search result below

ImmunoGen Q3 revenues up 10%; updates guidance

Nov. 03, 2017 6:51 AM ETImmunoGen, Inc. (IMGN) StockBy: SA News Team
  • ImmunoGen (NASDAQ:IMGN) Q3 results: Revenues: $8.5M (+10.4%); Operating Loss: ($31.1M) (+19.8%); Net Loss: ($56.7M) (-26.8%); Loss Per Share: ($0.61) (-19.6%); Quick Assets: $194.9M (+21.8%).
  • 2017 Guidance: Revenues: $115M - 120M (unch); Operating Expenses: $170M - 175M from $175M - 180M; Cash and cash equivalents: $260M - 265M from $90M - 95M.
  • Shares are down 1% premarket on modest volume.

Recommended For You

More Trending News

Related Stocks

SymbolLast Price% Chg
IMGN--
ImmunoGen, Inc.